Devyser wins Norwegian tender for Devyser CFTR at Oslo University Hospital
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
QF-PCR and maternal cell contamination by Dr Kathy Mann, the pioneer in prenatal QF-PCR analysis.
The ability to identify maternal cell contamination (MCC) in uncultured AF and CV samples minimises the risk of misdiagnosis due to the analysis of maternal cells. Authored by Dr. Kathy Manns, the pioneer in prenatal QF-PCR analysis, this paper provides information for laboratory professionals on how to identify the presence and level of MCC in a prenatal sample using a QF-PCR based approach.
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Read More
Devyser today announced that the Centers for Medicare & Medicaid Services (CMS) has issued its...
Read More